Investment16 Sept 2025, 06:40 pm
Authum Investment Acquires 3% Stake in Serovia Pharma for INR 3,000,000,153
AI Summary
Authum Investment & Infrastructure Ltd has entered into an investment agreement with Serovia Pharma Private Limited, a pharmaceutical company, to acquire 3% of its expanded share capital. The agreement involves the issuance and offering of 18,95,053 partly paid-up compulsorily convertible preference shares by Serovia Pharma, constituting 3% of its expanded share capital. The transaction is subject to certain pre-closing actions, including receipt of necessary corporate authorizations. Upon completion, Authum Investment will hold 3% of Serovia Pharma's expanded share capital. The acquisition aligns with Authum Investment's long-term strategy of diversifying its portfolio and investing in sectors with growth potential.
Key Highlights
- Authum Investment to acquire 3% of Serovia Pharma's expanded share capital for INR 3,000,000,153.
- The transaction involves the issuance and offering of 18,95,053 partly paid-up compulsorily convertible preference shares by Serovia Pharma.
- The acquisition aligns with Authum Investment's long-term strategy of diversifying its portfolio and investing in sectors with growth potential.
- The transaction is subject to certain pre-closing actions, including receipt of necessary corporate authorizations.
- Serovia Pharma is a pharmaceutical company intending to expand its presence to Cyprus and the US.